These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 6131703)

  • 21. [Neuroleptic malignant syndrome after 30 years treatment with clozapine: a rarely seen differential diagnosis on intensive care units].
    Franzen D; Burkhard J; Corti N; Schüpbach D; Fontanel D; Stäubli M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Feb; 41(2):125-7. PubMed ID: 16493563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anesthetic management for electroconvulsive therapy in the patients with a history of neuroleptic malignant syndrome].
    Setoyama K; Hirata T; Saeki H; Morimoto Y; Tsuruta S; Matsumoto M; Sakabe T
    Masui; 2009 May; 58(5):633-6. PubMed ID: 19462806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postoperative neuroleptic malignant syndrome that occurred repeatedly in a patient with cerebral palsy.
    Tsuchiya N; Morimura E; Hanafusa T; Shinomura T
    Paediatr Anaesth; 2007 Mar; 17(3):281-4. PubMed ID: 17263746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neuroleptic malignant syndrome].
    Murak E
    Psychiatr Pol; 1995; 29(3):349-58. PubMed ID: 7652088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
    Picard LS; Lindsay S; Strawn JR; Kaneria RM; Patel NC; Keck PE
    Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Four case reports.
    Luchini F; Lattanzi L; Bartolommei N; Cosentino L; Litta A; Kansky C; Mauri M; Cassano GB; Fagiolini A; Casamassima F
    J Nerv Ment Dis; 2013 Jan; 201(1):36-42. PubMed ID: 23274293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
    Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
    Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neuroleptic malignant syndrome. Case reports].
    Berardi D; Troia M; Veronesi L; Ferrari G
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lethal catatonia: clinical aspects and therapeutic intervention. A review of the literature].
    Mann SC; Auriacombe M; Macfadden W; Caroff SN; Cabrina Campbell E; Tignol J
    Encephale; 2001; 27(3):213-6. PubMed ID: 11488250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recognition, assessment and management of neuroleptic malignant syndrome.
    Khan M; Farver D
    S D J Med; 2000 Sep; 53(9):395-400. PubMed ID: 11016275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neuroleptic malignant syndrome: a review of literature].
    Crespo Facorro B; Carbonell Masia C
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(5):273-8. PubMed ID: 8553925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catatonia and neuroleptic malignant syndrome: two sides of a coin?
    Vancaester E; Santens P
    Acta Neurol Belg; 2007 Jun; 107(2):47-50. PubMed ID: 17710840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases.
    Goulon M; de Rohan-Chabot P; Elkharrat D; Gajdos P; Bismuth C; Conso F
    Neurology; 1983 Apr; 33(4):516-8. PubMed ID: 6682201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acute catatonia and neuroleptic malignant syndrome. A case of infantile psychosis].
    Revuelta E; Bordet R; Piquet T; Ghawche F; Destee A; Goudemand M
    Encephale; 1994; 20(3):351-4. PubMed ID: 7916282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The neuroleptic malignant syndrome. A priority system.
    Neppe VM
    S Afr Med J; 1984 Mar; 65(13):523-5. PubMed ID: 6143410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbamazepine in the treatment of neuroleptic malignant syndrome.
    Thomas P; Maron M; Rascle C; Cottencin O; Vaiva G; Goudemand M
    Biol Psychiatry; 1998 Feb; 43(4):303-5. PubMed ID: 9513741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
    Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L
    Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroleptic malignant syndrome: a case report.
    Fekadu A; Wakwoya A
    Ethiop Med J; 1999 Jul; 37(3):195-8. PubMed ID: 11957317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroleptic malignant syndrome without neuroleptics.
    Ong KC; Chew EL; Ong YY
    Singapore Med J; 2001 Feb; 42(2):85-8. PubMed ID: 11358199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.